For November 2026, no GLP-1 injury settlement or verdict has occurred, GSK settled most state Zantac cases, and the generic-drugs claim window just closed. A class action lets many people with the same drug injury or overpayment seek payment together.
This guide explains who each case affects and what to do next. It covers GLP-1 stomach and vision claims, Zantac claims, prenatal acetaminophen claims, and generic-drug overcharges. Use it to check your status, save records, and avoid missed deadlines.
Table of Contents
- Are GLP-1 stomach and vision claims one case?
- Can I still join Zantac litigation?
- What changed for acetaminophen autism and ADHD claims?
- Did I miss the generic-drugs refund deadline?
Are GLP-1 stomach and vision claims one case?
GLP-1 receptor agonists are prescription drugs for diabetes and weight control that act on gut hormones. The U.S. Food and Drug Administration says in its Drug Safety Communication that all GLP-1 labels must add NAION to Warnings and Precautions. NAION means a rare blockage of blood flow that causes sudden painless vision loss.
The Law Office of Melinda J. Helbock, citing federal court data updated October 20, 2026, counts about 4,025 stomach-injury cases in MDL 3094. It counts 247 vision-loss cases in a separate MDL pending October 1, 2026. The same source reports no settlement, verdict, or bellwether trial scheduled in either group.
Can I still join Zantac litigation?
Zantac is the brand name for ranitidine, a former heartburn drug tied to cancer claims. GSK said in its settlement statement that it agreed to pay up to $2.2 billion to resolve about 80,000 state-court cases. That deal covered about 93% of its state cases, subject to eligibility and participation rules.
ConsumerShield, in a review dated September 28, 2026, reports that federal MDL No. 2924 and Delaware claims were dismissed for unreliable expert science. It notes the Delaware dismissal on April 14, 2026, with federal and Delaware appeals still pending and no revival yet.
What changed for acetaminophen autism and ADHD claims?
These lawsuits claim that prenatal use of acetaminophen raised the risk of autism or ADHD in children. Marin and Murphy Law Firm explains in its JD Supra analysis that on July 13, 2026 the Second Circuit revived about 550 federal cases in Rutledge v. Walgreen.
The court reinstated three plaintiffs' general-causation experts and remanded a fourth. Schmidt and Clark, LLP reports on its litigation-status page that no court has found that prenatal acetaminophen causes autism or ADHD. It also reports that no Tylenol settlement has been announced. The ruling decided only expert admissibility for families seeking damages.
Did I miss the generic-drugs refund deadline?
This antitrust case concerns consumers and health plans that paid for covered generic drugs. Fine, Kaplan and Black said in its PR Newswire notice that end-payer claims for purchases from May 1, 2009 to December 31, 2019 were due November 9, 2026 at GenericDrugsEndPayerSettlement.com.
The same notice states that payments remain unannounced. If you filed, keep your confirmation and pharmacy records together.
- Save the claim confirmation number and filing email
- Keep pharmacy receipts showing drug, date, and amount paid
- Keep insurer statements showing reimbursement or copay